Cargando…
Methylation and copy number profiling: emerging tools to differentiate osteoblastoma from malignant mimics?
Rearrangements of the transcription factors FOS and FOSB have recently been identified as the genetic driver event underlying osteoid osteoma and osteoblastoma. Nuclear overexpression of FOS and FOSB have since then emerged as a reliable surrogate marker despite limitations in specificity and sensit...
Autores principales: | Ameline, Baptiste, Nathrath, Michaela, Nord, Karolin H., de Flon, Felix Haglund, Bovée, Judith V. M. G., Krieg, Andreas H., Höller, Sylvia, Hench, Jürgen, Baumhoer, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424109/ https://www.ncbi.nlm.nih.gov/pubmed/35347251 http://dx.doi.org/10.1038/s41379-022-01071-1 |
Ejemplares similares
-
NTRK fusions in osteosarcoma are rare and non‐functional events
por: Ameline, Baptiste, et al.
Publicado: (2020) -
Overactivation of the IGF signalling pathway in osteosarcoma: a potential therapeutic target?
por: Ameline, Baptiste, et al.
Publicado: (2020) -
Loss of NF2 defines a genetic subgroup of non‐FOS‐rearranged osteoblastoma
por: Saba, Karim H, et al.
Publicado: (2020) -
The early evolutionary landscape of osteosarcoma provides clues for targeted treatment strategies
por: Kovac, Michal, et al.
Publicado: (2021) -
Utility of FOS as diagnostic marker for osteoid osteoma and osteoblastoma
por: Lam, Suk Wai, et al.
Publicado: (2019)